Which of the following patient groups are considered to have a high risk of adverse outcomes from infective endocarditis (IE), excluding those with mitral valve prolapse (MVP)?
a) Individuals with prosthetic heart valves
b) Patients with a history of IE
c) Those with unrepaired congenital heart disease
d) None of the above